Rockland boosts life sciences portfolio with purchase of antibody line

21st Century Biochemicals agreed to sell its line of Epi-Plus antibodies, which are used in epigenetic studies, to Rockland Immunochemicals. The price was not disclosed. The deal will bolster Rockland's life science tools portfolio. The Epi-Plus brand is co-owned by Novus Biologicals.

View Full Article in:

Genetic Engineering & Biotechnology News · GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care